Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide

被引:0
|
作者
Schuelper, Nikolai [1 ]
Flohr, Antonius [2 ]
Truemper, Lorenz [1 ]
Wulf, Gerald G. [1 ]
机构
[1] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Dept Radiol, D-37075 Gottingen, Germany
关键词
MONOTHERAPY;
D O I
10.1007/s00277-014-2071-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1929 / 1930
页数:2
相关论文
共 50 条
  • [21] Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma
    Rodgers, Thomas D.
    Baran, Andrea
    Reagan, Patrick M.
    Casulo, Carla
    Zent, Clive
    Evans, Andrew
    Burack, Richard
    Williams, AnnaLynn M.
    Friedberg, Jonathan W.
    Barr, Paul M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : E33 - +
  • [22] Efficacy and safety of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
    Habermann, T.
    Lossos, I.
    Justice, G.
    Tuscano, J.
    Cole, C.
    Vose, J.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Wiernik, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 150 - 150
  • [23] Cell of Origin Impacts Δsuvmax Cutoff for Prediction of Relapse in Patients with Diffuse Large B-Cell Lymphoma
    Feres, Carolina
    Arcuri, Leonardo Javier
    Teixeira, Larissa L. C.
    Kerbauy, Mariana Nassif
    Pasqualin, Denise Cunha
    Bezerra, Alanna M. P. S.
    Campos Neto, Guilherme De Carvalho
    Nunes, Rafael Fernandes
    Ramos, Aline Fernanda
    Jacinto, Michelle De Paula
    Perini, Guilherme Fleury
    Hamerschlak, Nelson
    BLOOD, 2020, 136
  • [24] Checking in on Lenalidomide in Diffuse Large B Cell Lymphoma
    Goldfinger, Mendel
    Xu, Mina
    Bertino, Joseph R.
    Cooper, Dennis L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06): : E307 - E311
  • [25] An Investigation of Potential Prognostic Factors in Late Relapse Diffuse Large B-Cell Lymphoma Patients
    Robinson, Wilton Edward, Jr.
    Zhang, Yuzi
    Chen, Zhengjia
    Calzada, Oscar
    Churnetski, Michael C.
    Flowers, Christopher
    Cohen, Jonathon B.
    BLOOD, 2017, 130
  • [26] Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome
    Vannata, Barbara
    Conconi, Annarita
    Winkler, Jonas
    Cascione, Luciano
    Casaluci, Gloria Margiotta
    Nassi, Luca
    Moia, Riccardo
    Pirosa, Maria Cristina
    Moccia, Alden A.
    Stathis, Anastasios
    Rossi, Davide
    Gaidano, Gianluca
    Zucca, Emanuele
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (04) : 478 - 487
  • [27] CNS Relapse in Patients with Diffuse Large B-Cell Lymphoma, an Argentinian Retrospective Cohort Study
    Warley, Fernando
    Cristaldo, Nancy
    Colucci, Giuliana
    Otero, Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S290 - S290
  • [28] Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma
    Djebbari, Faouzi
    Browning, Joseph A.
    Stanton, Louise
    Booth, Stephen
    Hildyard, Catherine
    Willan, John
    Bosworth, Jenny
    Vora, Sona M.
    Hatton, Chris S. R.
    Collins, Graham P.
    Eyre, Toby A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (06) : E191 - E195
  • [29] Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B
    Lee, AYY
    Connors, JM
    Klimo, P
    OReilly, SE
    Gascoyne, RD
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1745 - 1753
  • [30] Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma
    Wang, Xiaoyan
    Yu, Lu
    Jiang, Xinlu
    Ding, Kaiyang
    CANCER MEDICINE, 2023, 12 (09): : 10553 - 10562